SCHEMBL6234769

SCHEMBL6234769

CC(C)CN1C(=O)c2ccc(C(F)(F)F)cc2C1=O.CC(C)CN1C(=O)c2ccc(C(F)(F)F)cc2C1=O

nearest known ligand 0.54

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.46
RAB9A P51151 8/20 0.46
KDM4E B2RXH2 2/20 0.46
HPGD P15428 2/20 0.46
MEN1 O00255 8/20 0.45
KMT2A Q03164 8/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
LMNA P02545 1/20 0.45
MAPK1 P28482 1/20 0.45
GAA P10253 1/20 0.45
NPC1 O15118 7/20 0.43
MAPT P10636 1/20 0.43
POLB P06746 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4463774 1.00 ALDH1A1 (0.46) ALDH1A1RAB9AKDM4EHPGDMEN1
SCHEMBL4473452 0.86 CA9 (0.52) ALDH1A1RAB9AKDM4EHPGDMEN1
SCHEMBL6230240 0.86 CA9 (0.52) ALDH1A1RAB9AKDM4EHPGDMEN1
SCHEMBL4462968 0.79 HPGD (0.40) ALDH1A1KDM4EHPGD
SCHEMBL6254603 0.77 RAB9A (0.59) ALDH1A1RAB9AKDM4EHPGDMEN1
SCHEMBL4471054 0.77 RAB9A (0.59) ALDH1A1RAB9AKDM4EHPGDMEN1
SCHEMBL5535855 0.76 ALDH1A1 (0.50) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL4468796 0.76 KDM4E (0.42) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL4463139 0.76 MEN1 (0.60) ALDH1A1RAB9AKDM4EHPGDMEN1
SCHEMBL13143053 0.76 CASP1 (0.53) ALDH1A1RAB9AKDM4EHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1528923-A1 N-((3-OXO-2,3-DIHYDRO-1H-ISOINDOL-1-YL)ACETYL)GUANIDINE DERIVATIVES AS NHE1-INHIBITORS FOR THE TREATMENT OF INFARCTION AND ANGINA PECTORIS Aventis Pharma Deutschland GmbH (DE) 2005-05-11 EP disclosed
WO-2003101450-A1 N- ((3-OXO2, 3-DIHYDRO-1H-ISOINDOL-1-YL) ACETYL) GUANIDINE DERIVATIVES AS NHE-1 INHIBITORS FOR THE TREATMENT OF INFARCTION AND ANGINA PECTORIS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-12-11 WO disclosed